TY  - JOUR
T1  - OMega-3 fatty acid supplementation and cardiovascular disease events
AU  - Sethi A, Singh M, Arora R
Y1  - 2013/01/02
N1  - 10.1001/jama.2012.116644
JO  - JAMA
SP  - 27
EP  - 27
VL  - 309
IS  - 1
N2  - 
To the Editor: The meta-analysis by Dr Rizos and colleagues1 synthesized the available evidence on omega-3 PUFA supplementation to prevent adverse cardiovascular outcomes. In addition to conventional random-effects meta-analyses, subgroup analyses and meta-regressions were performed. No association with type of prevention (ie, mixed or secondary) or omega-3 dose was found, and the authors did not demonstrate a net benefit from omega-3 PUFA supplementation after 2007. However, the type of omega-3 PUFA supplements and co-administered medications were not adequately explored.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.116644
UR  - http://dx.doi.org/10.1001/jama.2012.116644
ER  -